
Inmode Ltd (INMD) Stock Forecast & Price Target
Inmode Ltd (INMD) Analyst Ratings
Bulls say
InMode Ltd achieved a notable increase in its global installed base, selling 971 systems in the second quarter of 2025, resulting in a total of approximately 28,855 units, with around 12,347 units in the U.S., reflecting a 3.4% growth from the prior quarter. The company reported an operating margin of 27.5%, surpassing estimates and marking a 40 basis point improvement year-over-year. Additionally, the robust domestic sales of $49.7 million demonstrated a 9% growth, further emphasizing the expanding potential within the aesthetic market driven by rising consumer and physician interest.
Bears say
InMode Ltd faces a negative outlook primarily due to anticipated contraction in its profit margins, despite currently holding high margins within the med tech sector. Additionally, the company's earnings per share (EPS) growth is projected to lag behind revenue growth, contributing to investor concerns. Furthermore, a bear case scenario suggests a compound annual growth rate (CAGR) of less than 5% over the coming years, driven by underwhelming growth from existing products and slow adoption of new offerings.
This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.
Inmode Ltd (INMD) Analyst Forecast & Price Prediction
Start investing in Inmode Ltd (INMD)
Order type
Buy in
Order amount
Est. shares
0 shares